A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

620

Participants

Timeline

Start Date

September 12, 2019

Primary Completion Date

January 19, 2022

Study Completion Date

January 19, 2022

Conditions
Atopic Dermatitis
Interventions
DRUG

Crisaborole 2%

Crisaborole ointment 2%

DRUG

Vehicle

Vehicle ointment

Trial Locations (44)

2035

Australian Clinical Research Network, Maroubra

22015

PI-Coor Clinical Research LLC, Burke

32256

Clinical Neuroscience Solutions, Inc, Jacksonville

32801

Clinical Neuroscience Solutions, Inc, Orlando

33137

Baumann Cosmetic and Research Institute, Miami

33486

Skin Care Research LLC, Boca Raton

33770

Olympian Clinical Research, Largo

34093

Bezmialem Vakıf University Medical Faculty, Istanbul

38039

Erciyes University Medical Faculty, Kayseri

38119

Clinical Neuroscience Solutions, Inc., Memphis

45414

Ohio Pediatric Research Association, Inc., Dayton

46168

The Indiana Clinical Trials Center, PC, Plainfield

48706

Great Lakes Research Group, Inc., Bay City

68144

Skin Specialists PC, Omaha

70808

Meridian Clinical Research, LLC, Baton Rouge

73112

Lynn Health Science Institute, Oklahoma City

74127

Oklahoma State University - Center for Health Sciences, Tulsa

76244

Innovate Research, LLC, Fort Worth

77056

Austin Institute for Clinical Research, Houston

77598

Center for Clinical Studies, LTD. LLP, Webster

78660

Austin Institute for Clinical Research, Inc., Pflugerville

80907

Asthma and Allergy Associates, PC, Colorado Springs

80910

Colorado Springs Dermatology Clinic, PC, Colorado Springs

84095

Jordan Valley Dermatology Center, South Jordan

92708

First OC Dermatology, Fountain Valley

94538

Center for Dermatology Clinical Research, Inc., Fremont

99202

Dermatology Specialists of Spokane, Spokane

99204

Principle Research Solutions, Spokane

100034

Peking University First Hospital, Beijing

200040

Huashan Hospital Fudan University/Dermatology Department, Shanghai

300052

Tianjin Medical University General Hospital, Tianjin

310009

Hangzhou Third Hospital, Hangzhou

310016

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou

330000

Dermatology Hospital of Jiangxi Province, Nanchang

350005

The First Affiliated Hospital of Fujian Medical University, Fuzhou

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

510091

Dermatology Hospital of Southern Medical University, Guangzhou

650032

First Affiliated Hospital of Kunming Medical University, Kunming

5265601

The Chaim Sheba Medical Center, Ramat Gan

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Center, Barrie

N5W 6A2

Milestone Research , Inc, London

M2M 4J5

North York Research Inc., North York

M9W 4L6

Manna Research Toronto, Toronto

S7K 2C1

Skinsense Medical Research, Saskatoon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04040192 - A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis | Biotech Hunter | Biotech Hunter